Research Use Only - Not for Human Consumption
  • American Owned Lab
  • Affiliate Portal
  • Research Team
logo
  • Shop Peptides
  • Peptide Glossary
  • Peptide Research
  • Our Story
  • Contact Us
  • Search
  • Login / Register
  • Cart
  1. Home
  2. Research
  3. Tablet Blends-H
  4. Tri-Compound

Tri-Compound

$383.90

5 in stock

Maximum 5 units allowed per order.
  1. Home
  2. Research
  3. Tablet Blends-H
  4. Tri-Compound
Tri-Compound
$383.90
Add to Whishlist

5 in stock

Maximum 5 units allowed per order.

The Hanobi® Tri-Compound Research Blend is a precisely formulated tablet developed for advanced laboratory investigation of neurotrophic signaling, monoaminergic neurotransmission, and peptide-mediated cellular response pathways. This research combination integrates Dihexa, Tesofensine, and BPC-157—three compounds independently studied in preclinical models for their involvement in synaptic signaling, neurotransmitter regulation, and cellular remodeling mechanisms.

By combining these materials in fixed, standardized ratios, researchers can explore multi-target pathway interactions within controlled experimental environments. This formulation is intended exclusively for in vitro and preclinical research applications and does not imply human use.

Blend Composition Per Reference Unit

  • Dihexa — 10 mg
  • Tesofensine — 0.25 mg
  • BPC-157 — 0.125 mg

Dihexa
A synthetic angiotensin IV–derived peptide analogue studied in laboratory systems for its interaction with the hepatocyte growth factor (HGF)/c-Met signaling axis. Research focuses on synaptogenesis, dendritic branching, and neurotrophic pathway modulation under defined experimental conditions.

Tesofensine
A small-molecule compound characterized in research settings as a triple monoamine reuptake inhibitor affecting serotonin, norepinephrine, and dopamine transporters. Experimental models examine its influence on neurotransmitter dynamics and neuroendocrine signaling pathways.

BPC-157
A synthetic pentadecapeptide investigated in preclinical systems for its interaction with nitric oxide–associated signaling, angiogenic pathways, and extracellular matrix remodeling in cellular stress models.

Quality & Research Integrity

Hanobi® research compounds are manufactured under strict quality control standards using independently vetted raw material suppliers. Each component is analytically verified for identity and purity prior to formulation. Production processes are designed to ensure consistency, traceability, and compliance with federal and state regulations governing research-use-only materials.

Capsule Disclaimer

Capsules are supplied solely as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any manner.

For Research Use Only (RUO)

Not for use in humans or animals. Not for diagnostic or therapeutic purposes.

Peptides
Peptide TabletsPeptide BlendsIGF-1 ProteinsMelanotan PeptidesBioregulatorsCosmetic Peptides
Policies
Shipping PolicyRefund PolicyPrivacy PolicyTerms of Service
Company HQ
1810 E Sahara AveSTE 75963Las Vegas, NV 89104(702) 482-8555
Customer Support

support@hanobi.com

Shipping Days

Mon - Fri / Except HolidaysExpect 48 hours for order processing and 7 days (or more) for delivery.

Hanobi.com ©2026 All Rights Reserved

Accessibility Statement


All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. Bodily introduction of any kind—into humans or animals—is strictly prohibited by law.

All articles and product information provided on this website are for informational and educational purposes only. The products offered by Hanobi Peptides™ are furnished exclusively for in-vitro scientific research and development. In-vitro studies are conducted outside of the body, and these materials are not medicines, drugs, or therapeutic agents. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

Hanobi is a chemical supplier. Hanobi is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Hanobi is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

Privacy Preference Center

Privacy Preferences